These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 18452781)

  • 1. Clinical implications of the contrasting effects of in vivo thrombin receptor activation (protease-activated receptor type 1) on the human vasculature.
    Cleator JH; Vaughan DE
    J Am Coll Cardiol; 2008 May; 51(18):1757-9. PubMed ID: 18452781
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of the endothelium in the vascular effects of the thrombin receptor (protease-activated receptor type 1) in humans.
    Gudmundsdóttir IJ; Lang NN; Boon NA; Ludlam CA; Webb DJ; Fox KA; Newby DE
    J Am Coll Cardiol; 2008 May; 51(18):1749-56. PubMed ID: 18452780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease activated receptors 1 and 4 govern the responses of human platelets to thrombin.
    Ofosu FA
    Transfus Apher Sci; 2003 Jun; 28(3):265-8. PubMed ID: 12725953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked impairment of protease-activated receptor type 1-mediated vasodilation and fibrinolysis in cigarette smokers: smoking, thrombin, and vascular responses in vivo.
    Lang NN; Gudmundsdóttir IJ; Boon NA; Ludlam CA; Fox KA; Newby DE
    J Am Coll Cardiol; 2008 Jul; 52(1):33-9. PubMed ID: 18582632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease-activated receptor 4 uses anionic residues to interact with alpha-thrombin in the absence or presence of protease-activated receptor 1.
    Nieman MT
    Biochemistry; 2008 Dec; 47(50):13279-86. PubMed ID: 19053259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct vascular effects of protease-activated receptor type 1 agonism in vivo in humans.
    Gudmundsdóttir IJ; Megson IL; Kell JS; Ludlam CA; Fox KA; Webb DJ; Newby DE
    Circulation; 2006 Oct; 114(15):1625-32. PubMed ID: 17015787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteinase-activated receptor-1 (PAR(1)) and PAR(2) but not PAR(4) mediate contraction in human and guinea-pig gallbladders.
    Lee MC; Huang SC
    Neurogastroenterol Motil; 2008 Apr; 20(4):385-91. PubMed ID: 18179608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin signalling and protease-activated receptors.
    Coughlin SR
    Nature; 2000 Sep; 407(6801):258-64. PubMed ID: 11001069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin stimulates smooth muscle cell differentiation from peripheral blood mononuclear cells via protease-activated receptor-1, RhoA, and myocardin.
    Martin K; Weiss S; Metharom P; Schmeckpeper J; Hynes B; O'Sullivan J; Caplice N
    Circ Res; 2009 Jul; 105(3):214-8. PubMed ID: 19574550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin regulates vascular smooth muscle cell proteoglycan synthesis via PAR-1 and multiple downstream signalling pathways.
    Ivey ME; Little PJ
    Thromb Res; 2008; 123(2):288-97. PubMed ID: 18571697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypercoagulability inhibits monocyte transendothelial migration through protease-activated receptor-1-, phospholipase-Cbeta-, phosphoinositide 3-kinase-, and nitric oxide-dependent signaling in monocytes and promotes plaque stability.
    Seehaus S; Shahzad K; Kashif M; Vinnikov IA; Schiller M; Wang H; Madhusudhan T; Eckstein V; Bierhaus A; Bea F; Blessing E; Weiler H; Frommhold D; Nawroth PP; Isermann B
    Circulation; 2009 Sep; 120(9):774-84. PubMed ID: 19687358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of angiogenesis by small-molecule antagonists of protease-activated receptor-1.
    Tsopanoglou NE; Maragoudakis ME
    Semin Thromb Hemost; 2007 Oct; 33(7):680-7. PubMed ID: 18000795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular PAR-1: activity and antagonism.
    Lang NN; Guðmundsdóttir IJ; Newby DE
    Cardiovasc Ther; 2011 Dec; 29(6):349-61. PubMed ID: 20528879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of protease-activated receptor-1 by vasodilatory prostaglandins via NFAT.
    Rosenkranz AC; Rauch BH; Freidel K; Schrör K
    Cardiovasc Res; 2009 Sep; 83(4):778-84. PubMed ID: 19460777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional responses of bone cells to thrombin.
    Pagel CN; Sivagurunathan S; Loh LH; Tudor EM; Pike RN; Mackie EJ
    Biol Chem; 2006 Aug; 387(8):1037-41. PubMed ID: 16895473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of the endothelium in atherosclerosis].
    Tedgui A
    Rev Prat; 1997 Dec; 47(20):2262-7. PubMed ID: 9616916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin regulates matrix metalloproteinase-9 expression in human monocytes.
    Chang CJ; Hsu LA; Ko YH; Chen PL; Chuang YT; Lin CY; Liao CH; Pang JH
    Biochem Biophys Res Commun; 2009 Jul; 385(2):241-6. PubMed ID: 19454280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of thrombin receptors in vascular physiology and pathophysiology].
    Hirano K
    Fukuoka Igaku Zasshi; 2009 Jul; 100(7):248-57. PubMed ID: 19764478
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic potential of protease-activated receptor-1 antagonists.
    Derian CK; Maryanoff BE; Zhang HC; Andrade-Gordon P
    Expert Opin Investig Drugs; 2003 Feb; 12(2):209-21. PubMed ID: 12556215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of protease-activated receptors in the vascular system.
    Hirano K; Kanaide H
    J Atheroscler Thromb; 2003; 10(4):211-25. PubMed ID: 14566084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.